The MitraClip procedure is a minimally invasive, catheter-based treatment used to reduce mitral valve regurgitation, a condition in which blood flows backwards through the mitral valve. The Mitra Clip Procedure is a relevant treatment consideration for selected patients with significant mitral valve leakage, particularly those who are at high surgical risk or are unsuitable for conventional surgery.
Understanding how this procedure works, who may benefit from it and what recovery involves can help patients make informed decisions about their heart health.
What Is the MitraClip Procedure?
The mitral valve controls blood flow between the left atrium and left ventricle. Normally, it opens to allow blood to pass into the left ventricle and closes to prevent blood from flowing backwards.
When the valve does not close properly, a condition called mitral valve regurgitation develops. This can increase the workload on the heart and, if severe and left untreated, may contribute to heart failure.
The MitraClip device is used during a procedure called transcatheter edge-to-edge repair (TEER). It brings the mitral valve leaflets closer together, helping them close more effectively and reducing the backward flow of blood.
Unlike conventional open-heart surgery, this approach uses a catheter inserted through a blood vessel, usually in the groin. It does not require opening the chest or stopping the heart.

Who May Be Eligible for MitraClip Treatment?
MitraClip treatment is not suitable for every patient with mitral valve regurgitation. Eligibility depends on the severity and cause of the leakage, valve anatomy, heart function, symptoms and overall medical condition.
A cardiologist may consider the procedure for selected patients who have:
- Severe symptomatic mitral valve regurgitation.
- Persistent symptoms despite appropriate medical treatment.
- A high or prohibitive risk associated with conventional heart surgery.
- Suitable mitral valve anatomy for clip placement.
- Clinical findings that suggest a reasonable likelihood of benefit.
In patients with primary mitral regurgitation, surgical repair generally remains the preferred treatment when an operation is appropriate and the patient is at acceptable surgical risk. TEER may be considered for selected high-risk patients.
For secondary mitral regurgitation, treatment usually begins with optimising heart failure medications and other indicated therapies. TEER may be appropriate for carefully selected patients whose symptoms continue despite appropriate treatment.
How Is the MitraClip Procedure Performed?
The MitraClip procedure is performed in a specialised cardiac catheterisation laboratory with continuous imaging guidance.
1. Pre-procedure evaluation
Before the intervention, the medical team reviews the patient’s symptoms, medical history, medications and previous cardiac investigations.
Echocardiography is particularly important. A transoesophageal echocardiogram (TEE), sometimes with three-dimensional imaging, helps assess the valve structure, severity of leakage and suitability for clip placement.
2. Catheter insertion
The procedure is generally performed under general anaesthesia, although the anaesthesia approach can vary.
A catheter is introduced through a vein in the groin and guided towards the heart. The specialist uses imaging to guide the catheter through the interatrial septum and towards the mitral valve.
3. Clip placement
The MitraClip device is carefully positioned to bring the mitral valve leaflets together.
Once the clip is placed, echocardiographic imaging helps the medical team assess how much the backward blood flow has reduced and whether the valve continues to open adequately.
4. Completion and monitoring
After confirming the result, the catheter is removed. The patient is then monitored for changes in heart rhythm, blood pressure, access-site bleeding and other possible complications.

What Are the Benefits and Risks of MitraClip Treatment?
The potential benefits depend on the patient’s underlying condition and suitability for the procedure.
Possible benefits include:
- Reduction in mitral valve leakage.
- Improvement in breathlessness and other symptoms in appropriately selected patients.
- A catheter-based alternative for certain patients at high surgical risk.
- Avoidance of a conventional chest-opening operation.
- Potential improvement in functional capacity and quality of life.
However, MitraClip treatment also has potential risks. These include bleeding, blood vessel injury, infection, stroke, abnormal heart rhythms, damage to surrounding structures, residual valve leakage and narrowing of the mitral valve opening.
In some cases, the clip may not achieve the intended result, and additional treatment or surgery may be required.
It is important to understand that a minimally invasive procedure is not a risk-free procedure. The expected benefits and possible complications should be discussed before treatment.
Recovery After the MitraClip Procedure
Recovery varies depending on the patient’s age, heart function, other medical conditions and procedural outcome.
Patients are monitored after the intervention, and the medical team may perform follow-up echocardiography to evaluate valve function.
The recovery plan generally includes:
- Following prescribed medication instructions.
- Keeping the catheter insertion site clean and monitoring for bleeding or swelling.
- Gradually returning to everyday activities as advised.
- Attending scheduled cardiology appointments.
- Undergoing follow-up echocardiography when recommended.
Patients should seek medical attention if they experience new or worsening breathlessness, chest pain, fainting, fever or significant bleeding from the catheter insertion site.
There is no single recovery timeline that applies to everyone. Activity restrictions and discharge decisions should be based on individual clinical assessment.
MitraClip vs Open-Heart Mitral Valve Surgery: What Is the Difference?
Both approaches aim to address mitral valve regurgitation, but they differ in how the valve is treated.
Open-heart surgery allows the surgeon to repair or replace the valve directly. It remains an important treatment option, particularly for patients with severe primary mitral regurgitation who are suitable surgical candidates.
MitraClip uses a catheter-based approach to bring the valve leaflets together without conventional open-heart surgery. It may be considered when surgical risk is high and the valve anatomy is suitable.
The choice should not be based simply on which procedure is less invasive. Valve anatomy, age, heart function, associated conditions and long-term treatment goals all matter.

Understanding MitraClip Care at Be Heart Healthy
At Be Heart Healthy, understanding the underlying valve condition is an important part of making informed treatment decisions.
Dr. Ankur Phatarpekar’s approach to structural heart disease focuses on evaluating the severity of valve dysfunction, understanding the patient’s symptoms and reviewing cardiac imaging before considering an intervention.
For patients with mitral valve regurgitation, the important question is not simply whether a catheter-based procedure is available. It is whether the procedure is clinically appropriate and whether its expected benefits outweigh the risks for that individual.
For additional educational information, patients can also explore the overview of structural heart and valve-related care and the article on understanding heart valve treatment options.
Dr. Ankur Phatarpekar Clinical Perspective
Dr. Ankur Phatarpekar emphasises the importance of understanding why a patient’s mitral valve is leaking before deciding on an intervention.
In clinical decision-making, the severity of regurgitation is only one part of the assessment. Symptoms, left ventricular function, pulmonary pressures, valve anatomy and associated medical conditions also influence treatment planning.
A patient with primary mitral regurgitation may benefit more from surgical repair if the operative risk is acceptable. Another patient with significant symptoms, secondary mitral regurgitation and persistent problems despite optimised medical treatment may be considered for TEER.
The objective is to identify the most appropriate treatment rather than assume that one procedure is suitable for everyone. A multidisciplinary Heart Team assessment helps bring together the necessary clinical and imaging information before a decision is made.
Frequently Asked Questions About the MitraClip Procedure
Patients and families often have questions about the procedure, its suitability and what to expect afterwards. Here are some common questions.
Q. Is the MitraClip procedure a minimally invasive treatment?
Yes. It is a catheter-based procedure that generally uses a vein in the groin to access the heart. It does not require conventional open-heart surgery.
Q. Who is the right candidate for MitraClip treatment?
Selected patients with significant symptomatic mitral regurgitation, suitable valve anatomy and an appropriate clinical risk profile may be considered. A detailed echocardiographic assessment and Heart Team evaluation are essential.
Q. How long does recovery take after the MitraClip procedure?
Recovery differs between patients. Hospital monitoring, overall health, procedural findings and any complications influence the recovery period. The treating team provides individual activity and follow-up instructions.
Q. Is MitraClip better than open-heart surgery?
Neither approach is universally better. Surgical repair remains preferred for many suitable patients with primary mitral regurgitation, while MitraClip may be considered for selected patients at high surgical risk. The choice depends on individual clinical findings.
Q. Can mitral valve regurgitation be treated without open-heart surgery?
Yes. Selected patients may be suitable for catheter-based approaches such as TEER. You can read more about heart valve treatment options to understand the differences between available interventions.
Q. Does every patient with mitral valve regurgitation need a MitraClip?
No. Mild or moderate regurgitation may not require an intervention, while other patients may benefit from medication, surgical repair or a transcatheter procedure. Treatment depends on the underlying cause, severity and clinical assessment.
General Clinic Information – Be Heart Healthy
At Be Heart Healthy, we believe that understanding your heart condition is an important part of making informed healthcare decisions. For general information about cardiac health and available treatment options, you can reach us through the contact details below.
Phone: +91 88284-73147
Email: careforyourheart.in@gmail.com
Address: A12 Silver Apts, Shankar Ghanekar Marg, Prabhadevi, Mumbai 400025, Maharashtra, India
This article provides general educational information and does not replace an individual medical assessment. Treatment decisions should be made by the treating cardiologist and multidisciplinary Heart Team based on the patient’s clinical findings.